Search Results - Choong, Nicholas

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Pemetrexed induced pneumonitis

    Pemetrexed induced pneumonitis by Dhakal, Binod, Singh, Veerpal, Shrestha, Anuj, Rao, Arjun, Choong, Nicholas

    Published 2011
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Morbidities of Lung Cancer Surgery in Obese Patients

    Morbidities of Lung Cancer Surgery in Obese Patients by Dhakal, Binod, Eastwood, Daniel, Sukumaran, Sunitha, Hassler, George, Tisol, William, Gasparri, Mario, Choong, Nicholas, Santana-Davila, Rafael

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Effect of Hepatic Impairment on Cobimetinib Pharmacokinetics: The Complex Interplay Between Physiological Changes and Drug Characteristics

    Effect of Hepatic Impairment on Cobimetinib Pharmacokinetics: The Complex Interplay Between Physiological Changes and Drug Characteristics by Cheeti, Sravanthi, Deng, Yuzhong, Chang, Ilsung, Georgescu, Isabela, Templeton, Ian, Choong, Nicholas, Cheung, Kit Wun Kathy, Girish, Sandhya, Musib, Luna

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Biomarker analysis of on-treatment and at progression biopsies from BRIM7 - a phase 1B trial of combined vemurafenib and cobimetinib treatment in BRAF V600 mutated melanoma

    Biomarker analysis of on-treatment and at progression biopsies from BRIM7 - a phase 1B trial of combined vemurafenib and cobimetinib treatment in BRAF V600 mutated melanoma by Yan, Yibing, McArthur, Grant, Hamid, Omid, Puzanov, Igor, Gonzalez, Rene, Gajewski, Thomas, Wang, Yulei, Wongchenko, Matthew, Choong, Nicholas, Ribas, Antoni

    Published 2014
    Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAF(V600)- mutated melanoma (BRIM7)

    Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAF(V600)- mutated melanoma (BRIM7) by Puzanov, Igor, McArthur, Grant, Gonzalez, Rene, Pavlick, Anna, Hamid, Omid, Gajewski, Thomas F, Yin, Ming, Fredrickson, Jill, Choong, Nicholas, Ribas, Antoni

    Published 2014
    Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer

    MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer by Parikh, Aparna R., Lee, Fa-Chyi, Yau, Linda, Koh, Han, Knost, James, Mitchell, Edith P., Bosanac, Ivan, Choong, Nicholas, Scappaticci, Frank, Mancao, Christoph, Lenz, Heinz-Josef

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    EphA2 Mutation in Lung Squamous Cell Carcinoma Promotes Increased Cell Survival, Cell Invasion, Focal Adhesions, and Mammalian Target of Rapamycin Activation

    EphA2 Mutation in Lung Squamous Cell Carcinoma Promotes Increased Cell Survival, Cell Invasion, Focal Adhesions, and Mammalian Target of Rapamycin Activation by Faoro, Leonardo, Singleton, Patrick A., Cervantes, Gustavo M., Lennon, Frances E., Choong, Nicholas W., Kanteti, Rajani, Ferguson, Benjamin D., Husain, Aliya N., Tretiakova, Maria S., Ramnath, Nithya, Vokes, Everett E., Salgia, Ravi

    Published 2010
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Phase I Study of Induction Chemotherapy and Concomitant Chemoradiotherapy with Irinotecan, Carboplatin, and Paclitaxel for Stage III Non-small Cell Lung Cancer

    Phase I Study of Induction Chemotherapy and Concomitant Chemoradiotherapy with Irinotecan, Carboplatin, and Paclitaxel for Stage III Non-small Cell Lung Cancer by Choong, Nicholas W., Vokes, Everett E., Haraf, Daniel J., Tothy, Peter K., Ferguson, Mark K., Kasza, Kristen, Rudin, Charles M., Hoffman, Philip C., Krauss, Stuart A., Szeto, Livia, Mauer, Ann M.

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Phase I Trial of Erlotinib-Based Multimodality Therapy for Inoperable Stage III Non-small Cell Lung Cancer

    Phase I Trial of Erlotinib-Based Multimodality Therapy for Inoperable Stage III Non-small Cell Lung Cancer by Choong, Nicholas W., Mauer, Ann M., Haraf, Daniel J., Lester, Eric, Hoffman, Philip C., Kozloff, Mark, Lin, Shang, Dancey, Janet E., Szeto, Livia, Grushko, Tatyana, Olopade, Olufunmilayo I., Salgia, Ravi, Vokes, Everett E.

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: